L'antibiothérapie dans la mucoviscidose: II. Stratégie antibiotique
- 30 June 2000
- journal article
- abstracts
- Published by Elsevier in Archives de Pédiatrie
- Vol. 7 (6), 645-656
- https://doi.org/10.1016/s0929-693x(00)80134-7
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Comparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosisThe Journal of Pediatrics, 1999
- Long-term azithromycin may improve lung function in children with cystic fibrosisThe Lancet, 1998
- Continuous Infusion of ??-Lactam AntibioticsClinical Pharmacokinetics, 1998
- Nutritional impact of antipseudomonas intravenous antibiotic courses in cystic fibrosisArchives of Disease in Childhood, 1997
- Management of Pulmonary Disease in Patients with Cystic FibrosisNew England Journal of Medicine, 1996
- Role of anti-pseudomonal antibiotics in the emergence ofStenotrophomonas maltophilia in cystic fibrosis patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosisThe Journal of Pediatrics, 1988
- Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosaRespiratory Medicine, 1987
- Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosisThe Journal of Pediatrics, 1987
- Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?The Journal of Pediatrics, 1980